Clinical Trials Sponsored by Alfact Innovation

Total 2097 results

Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix (RESULTS)

Obesity

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation

Rotator Cuff Tear

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

Acute Achilles Repair With or Without OrthADAPT Augmentation

Achilles Tendon Tear

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer

Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Trial of Poor Performance Status Patients (ToPPS) (ToPPS)

Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Completed

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

Metastatic Pancreatic Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Treatment of Head & Neck Cancer With Chemotherapy and Radiation

Head and Neck Cancer

United States
Baxter Healthcare Corporation
Baxter Innovations GmbH

Completed

Oxidized Cellulose hEmostAsis evaluatioN (OCEAN)

Intra-operative Bleeding

Czech Republic, Germany, Hungary, Poland
SCRI Development Innovations, LLC
Celgene Corporation

Completed

Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Terminated

Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer

Breast Cancer
SCRI Development Innovations, LLC
Aventis Pharmaceuticals

Completed

Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer

Breast Cancer
French Innovative Leukemia Organisation

Completed

Efficacity of Idelalisib and Obinutuzumab in Patient With Relapsed Refractory Waldenstrom's Macroglobulinemia (RemodelWM3)

Waldenstrom Macroglobulinemia

France
French Innovative Leukemia Organisation

Active, not recruiting

Dexamethasone Added to Intensive Chemotherapy in Older Patients With Acute Myeloid Leukemia (AML) (DEXAML-02)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation

Completed

Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg (RUXOPeg)

Myelofibrosis

France
French Innovative Leukemia Organisation

Completed

Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL

B Cell Chronic Lymphocytic Leukemia

France
French Innovative Leukemia Organisation

Terminated

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

B-cell Lymphoma

France
French Innovative Leukemia Organisation

Terminated

Treatment of Aggressive Localized Lymphoma

B Cell Lymphoma

France
Oculus Innovative Sciences, Inc.

Completed

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

Foot Ulcer, Diabetic

United States
SCRI Development Innovations, LLC
Sirtex Medical

Completed

Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

Colorectal Neoplasms

United States
SCRI Development Innovations, LLC
Novartis Pharmaceuticals

Terminated

LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies

Small Cell Lung Cancer | Ovarian Cancer

United States
Mucosa Innovations, S.L.
Universidad de Granada

Active, not recruiting

Study on the Effects of a Toothpaste in the Microbiome and Clinical Parameters in Patients With Oral Dysbiosis

Oral Dysbiosis

Spain
Novavax
Coalition for Epidemic Preparedness Innovations

Completed

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

COVID-19

United States, Australia
SCRI Development Innovations, LLC
Bayer; Novartis

Completed

Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer

Kidney Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer

Esophageal Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Colorectal Cancer | Rectal Cancer | Cancer of the Rectum

United States
Vascular Innovations Co. Ltd.
MedPass International

Active, not recruiting

A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve

Aortic Valve Stenosis

New Zealand, Hong Kong, Thailand, Greece, Lithuania, Poland
SCRI Development Innovations, LLC
Novartis Pharmaceuticals

Completed

Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer

Prostate Cancer

United States
Urovant Sciences GmbH
Ion Channel Innovations

Terminated

Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

Overactive Bladder

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; Celgene

Withdrawn

Study of Trametinib and Nab-paclitaxel in Patients With Melanoma

Melanoma

United States
Urovant Sciences GmbH
Ion Channel Innovations

Completed

Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer (OAB)

Overactive Bladder

United States
Cambridge Respiratory Innovations Limited
Innovate UK

Completed

The General Breathing Record Study (GBRS)

Heart Failure | Pneumonia | Motor Neuron Disease | Asthma | Vocal Cord Dysfunction | Breathlessness

United Kingdom
Baxter Healthcare Corporation
Synovis Surgical Innovations

Terminated

Veritas in Non-Bridging Ventral Hernia Repair (VIBE)

Hernia

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; Novartis

Completed

Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)

Necrosis | Infection | Seroma

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers

Venous Leg Ulcers

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Terminated

Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma

Primary Central Nervous System Lymphoma

United States
SCRI Development Innovations, LLC
Eisai Inc.

Completed

Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer

HER2 Negative Breast Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers

Neuroendocrine Carcinoma

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

High-dose Bevacizumab in Advanced Renal Carcinoma Patients

Kidney Cancer | Renal Cancer

United States
SCRI Development Innovations, LLC
Biotheranostics, Inc.

Completed

Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer

Unknown Primary Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Completed

CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas

Pancreatic Cancer

United States
SCRI Development Innovations, LLC
Aventis Pharmaceuticals

Completed

Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer

Breast Cancer
SCRI Development Innovations, LLC
Aventis Pharmaceuticals

Completed

Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer

Prostate Cancer

United States
SCRI Development Innovations, LLC
CTI BioPharma

Completed

Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site

Neoplasms, Unknown Primary
SCRI Development Innovations, LLC
Aventis Pharmaceuticals

Completed

Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients

Lung Cancer

United States
SCRI Development Innovations, LLC
CTI BioPharma

Completed

Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma

Multiple Myeloma
University of Valencia
Ministry of Science and Innovation

Not yet recruiting

Mobile App for Obsessive-compulsive Disorder in Adolescents

Obsessive-Compulsive Disorder in Adolescence

Spain
Institute of HIV Research and Innovation Foundation...

Completed

Undetectable = Untransmissible in Thailand (888/64) (888/64)

HIV

Thailand
Center for Social Innovation, Massachusetts
West Haven VA

Completed

Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment (OASIS)

Opioid Use Disorder

United States

Clinical Trials Sponsored by Alfact Innovation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations